In the PET trial, RAP-219 achieved and exceeded target receptor occupancy, increasing support for the dosing regimen utilized in the…
The partnership reached initial go-live in three weeks, showcasing the impressive speed and scalability of Aidoc's aiOS™ platform HARTFORD, Conn.,…
Advancing a deep pipeline of therapeutics focused on treating neurological, cardiometabolic, and ophthalmic diseases Led by expert R&D leadership team…
BETHESDA, Md., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology…
Correction: This release has been updated to reflect accurate specialty-focused EHR top ratings. NextGen Healthcare has achieved five specialty-focused EHR…
SAN FRANCISCO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to…
Top EHR Vendors Shine in Multiple Specialties: ModMed, NextGen Healthcare, Netsmart, ClinicMind, Epic, and RXNT Lead the Pack TAMPA, FLORIDA…
54 Specialty EHR Vendors Across 17 Categories Mark New Entries in the 2024 Black Book Surveys with High Satisfaction Marks…
25 EHR Vendors Recognized Across 40 Physician Specialties, with ModMed, NextGen, Netsmart, ClinicMind, Epic, and RXNT Leading in Multiple Categories…
BOSTON, MA / ACCESSWIRE / January 2, 2025 / Radius Pharmaceuticals, Inc., a wholly owned subsidiary of Radius Health, Inc.…
